Skip to main content
  • Site Staff Website Access Request Form
  • Connect With Us
  • Login

Search form

Home
  • About BMT CTN
    • What We Do
    • Why We Do What We Do
    • Who’s Involved
    • Clinical Centers
    • Enrollment in BMT CTN Studies
    • Our Annual Progress Report
    • Publications
    • State of the Science Symposia
    • Our History
    • Study Summaries for Patients
  • BMT CTN Studies
  • Investigator & Research Staff Resources
    • Overview
    • Administrative Manual of Procedures (MOP)/Policy Guidelines
    • Center Membership & Study Participation
    • Resources for Research Coordinators
    • Correlative Study Proposals
    • Funding Opportunities
    • Technical and Administrative Committees
    • Author Resources
  • Partner With Us

Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials.

TitleEasy-to-read informed consent forms for hematopoietic cell transplantation clinical trials.
Publication TypeJournal Article
Year of Publication2012
AuthorsDenzen, EM, Santibáñez, MEBurton, Moore, H, Foley, A, Gersten, ID, Gurgol, C, Majhail, NS, Spellecy, R, Horowitz, MM, Murphy, EA
JournalBiol Blood Marrow Transplant
Volume18
Issue2
Pagination183-9
Date Published2012 Feb
ISSN1523-6536
KeywordsClinical Trials as Topic, Humans, Medical Records, National Cancer Institute (U.S.), National Heart, Lung, and Blood Institute (U.S.), United States
Abstract

Informed consent is essential to ethical research and is requisite to participation in clinical research. Yet most hematopoietic cell transplantation (HCT) informed consent forms (ICFs) are written at reading levels that are above the ability of the average person in the United States (U.S.). The recent development of ICF templates by the National Cancer Institute, National Institutes of Health, and the National Heart Blood and Lung Institute have not resulted in increased patient comprehension of information. Barriers to creating Easy-to-Read ICFs that meet U.S. federal requirements and pass institutional review board (IRB) review are the result of multiple interconnected factors. The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) formed an ad hoc review team to address concerns regarding the overall readability and length of ICFs used for BMT CTN trials. This paper summarizes recommendations of the review team for the development and formatting of Easy-to-Read ICFs for HCT multicenter clinical trials, the most novel of which is the use of a 2-column format. These recommendations intend to guide the ICF writing process, simplify local IRB review of the ICF, enhance patient comprehension, and improve patient satisfaction. The BMT CTN plans to evaluate the impact of the Easy-to-Read format compared with the traditional format on the informed consent process.

DOI10.1016/j.bbmt.2011.07.022
Alternate JournalBiol Blood Marrow Transplant
PubMed ID21806948
PubMed Central IDPMC3242929
Grant ListU10 HL069294 / HL / NHLBI NIH HHS / United States
U10 HL069290 / HL / NHLBI NIH HHS / United States
U10 HL069294-11 / HL / NHLBI NIH HHS / United States
U10 HL069330 / HL / NHLBI NIH HHS / United States
U01 HL069294 / HL / NHLBI NIH HHS / United States
U10 HL069348 / HL / NHLBI NIH HHS / United States
U24 CA076518 / CA / NCI NIH HHS / United States
U01HL069294 / HL / NHLBI NIH HHS / United States
  • Google Scholar
  • PubMed
  • DOI

Blood & Marrow Transplant Clinical Trials Network (BMT CTN)

Blood and Marrow Transplant Clinical Trials Network Twitter

Copyright © 2023, The Emmes Company LLC